Načítá se...
Systemic adjuvant therapies in renal cell carcinoma
Renal cell carcinoma (RCC) is one of the ten most frequent solid tumors worldwide. Recent innovations in the treatment of metastatic disease have led to new therapeutic approaches being investigated in the adjuvant setting. Observation is the only current standard of care after radical nephrectomy,...
Uloženo v:
| Vydáno v: | Oncol Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419621/ https://ncbi.nlm.nih.gov/pubmed/25992216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2012.e18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|